Anti-LRRC15 antibody drug conjugates

TW202635683APending Publication Date: 2026-09-01BRISTOL MYERS SQUIBB CO
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114145596
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-11-17
Filing Date
2025-11-21
Publication Date
2026-09-01

Smart Images

  • Figure TWG2TA001074731_001
    Figure TWG2TA001074731_001
  • Figure TWG2TA001074731_002
    Figure TWG2TA001074731_002
  • Figure TWG2TA001074731_003
    Figure TWG2TA001074731_003
Patent Text Reader

Abstract

Provided herein are antibody drug conjugates of the formula (I) comprising an anti-LRRC15 antibodies, antigen binding portions thereof that is conjugated with a linker and exatecan. The disclosure also provides a method of treating cancer in a subject in need thereof comprising administering to the subject an antibody drug conjugate disclosed herein.
Need to check novelty before this filing date? Find Prior Art